Lipogems
-
Regulatory
Lipogems Announces Last Patient Enrolled in the U.S. FDA IDE Arise Study for the Treatment of Knee Osteoarthritis
Orthopaedic surgeon, Dr. Cristin Mathew, enrolls a patient in the Lipogems ARISE US FDA IDE Knee OA Study ATLANTA, April 10,…
Read More » -
Regulatory
Lipogems Announces First Patient Enrolled in the Second U.S. FDA IDE Study for the Treatment of Knee Osteoarthritis
Orthopaedic surgeon, Dr. Yogesh Mittal, enrolls the first patient in the ARISE 2 Study for Knee Osteoarthritis ATLANTA, April 8, 2024 /PRNewswire/…
Read More » -
Biologics
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study…
Read More » -
Financial
Lipogems Raises €12.5M ($13.2M) to Accelerate the Expansion in Knee Osteoarthritis
ATLANTA, Dec. 26, 2022 /PRNewswire/ — Lipogems, a clinical stage- global medical technology company that utilizes autologous adipose tissue for therapeutic use in…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Biologics
Lipogems Provides Orthopaedic Patients With Another Option To Major Invasive Surgery
ATLANTA, Jan. 14, 2019 /PRNewswire/ — The Lipogems system is leading the way in reparative medicine by providing patients another option to major,…
Read More » -
Hospitals
FDA Clears The Way: Lipogems’ Receives FDA Clearance For Microfragmented Adipose Tissue System Utilizing Body’s Own Fat To Support Tissue Repair In Orthopaedic And Arthroscopic Surgeries
NORCROSS, Ga., July 5, 2018 /PRNewswire/ — Lipogems, a leader in medical technologies for orthopaedic physicians, announced U.S. Food and Drug Administration (FDA)…
Read More »